[Hypodysfibrinogenemia: fibrinogen giessen II (author's transl)].
A new case of facultative hemorrhagic diathesis is described in a 19 year old female and the coagulatory anomaly examined. The experiments show that the coagulatory disturbance should be ascribed to a defective aggregation of fibrin monomers associated with hypofibrinogenemia. Some of its characteristics are the markedly prolonged thrombin-, reptilase-time as well prolonged prothrombin and partial thromboplastin time. The plasma fibrinogen concentration measured by the immunologic method is reduced. The streptokinase induced digestion of fibrinogen Giessen II plasma occurred at a slower rate than normal plasma with persistence of the large fibrinogen degradation products. Fibrinogen Giessen II appears to be a congenital hypodysfibrinogenemia with abnormality of fibrinogen resulting in delayed coagulation and a retarded fibrinogenolysis rate.
D000328:Adult; D000347:Afibrinogenemia / Q000150:complications / Q000151:congenital* / Q000503:physiopathology; D012103:Batroxobin; D005260:Female; D005337:Fibrin / Q000378:metabolism; D005340:Fibrinogen / Q000032:analysis* / Q000378:metabolism; D005342:Fibrinolysis; D006474:Hemorrhagic Disorders / Q000209:etiology* / Q000503:physiopathology; D006801:Humans; D013300:Streptokinase / Q000494:pharmacology; D013917:Thrombin / Q000096:biosynthesis; D013925:Thromboplastin / Q000096:biosynthesis
D005337:Fibrin; D005340:Fibrinogen; D013925:Thromboplastin; D013300:Streptokinase; D012103:Batroxobin; D013917:Thrombin
Hypodysfibrinogenämie: Fibrinogen Giessen II